Interestingly, studies on different lung cancer cell lines suggested that NCI-H292, a pulmonary MEC cell line that has wild-type EGFR, is more sensitive to gefitinib than other wild-type EGFR non-small cell lung cancer cell lines [19]. The gene discussed is EGFR; the disease is small cell lung carcinoma.